Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1226048)	5/1/2020 7:29:10 PM
From: sylvester80	Read Replies (1) \| Respond to of 1572953

>>>The death rate for those getting treated with Remdesivir was 8.0% vs. 11.6% for the placebo group. To be sure, that difference isn't considered "clinically significant," but it's still a positive data point. And that is exactly what the much larger China study found. That Remdesivir is junk.

To: Tenchusatsu who wrote (1226048)	5/1/2020 7:34:14 PM
From: sylvester80	Respond to of 1572953

>>>But the truth is that once again American capitalism and American ingenuity is coming out on top. If you mean 8% death rate versus 11.6% death rate with nothing is "ingenuity is coming out on top", you are an even bigger joker clown than I already thought... Now watch how the rest of the democratic socialist world comes up with way better numbers than those and an antiviral drug that actually works. And unlike shithole U.S., they will make it available to everyone...

To: Tenchusatsu who wrote (1226048)	5/1/2020 8:39:07 PM
From: Brumar89	Respond to of 1572953

GILD is my second largest stock holding and I've owned it long before I ever heard of covid19.